Procter & Gamble Company (The) (NYSE:PG - Get Free Report) was the recipient of some unusual options trading activity on Monday. Stock investors acquired 35,981 call options on the company. This is an increase of 46% compared to the average daily volume of 24,569 call options.
Procter & Gamble Price Performance
Shares of PG stock traded up $2.87 during trading hours on Monday, hitting $172.66. The company had a trading volume of 6,299,287 shares, compared to its average volume of 9,717,642. Procter & Gamble has a 12 month low of $137.62 and a 12 month high of $173.57. The company has a debt-to-equity ratio of 0.40, a quick ratio of 0.53 and a current ratio of 0.72. The firm's fifty day moving average is $154.26 and its 200 day moving average is $149.93. The firm has a market capitalization of $400.20 billion, a price-to-earnings ratio of 25.99, a PEG ratio of 4.18 and a beta of 0.36.
Procter & Gamble (NYSE:PG - Get Free Report) last announced its quarterly earnings results on Thursday, October 22nd. The company reported $2.00 EPS for the quarter, beating the consensus estimate of $1.89 by $0.11. Procter & Gamble had a return on equity of 31.02% and a net margin of 18.23%. The business had revenue of $23.28 billion for the quarter, compared to analyst estimates of $22.80 billion. During the same quarter in the previous year, the firm earned $1.99 EPS. Procter & Gamble's quarterly revenue was up 4.0% on a year-over-year basis. On average, sell-side analysts predict that Procter & Gamble will post 6.99 EPS for the current fiscal year.
Procter & Gamble Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Monday, November 16th. Stockholders of record on Friday, October 23rd will be issued a $1.0885 dividend. The ex-dividend date of this dividend is Friday, October 23rd. This represents a $4.35 annualized dividend and a dividend yield of 2.5%. Procter & Gamble's dividend payout ratio is presently 65.51%.
Analyst Upgrades and Downgrades
Several analysts have recently weighed in on the company. Weiss Ratings raised Procter & Gamble from a "hold (c)" rating to a "hold (c+)" rating in a report on Friday. Wells Fargo & Company upped their target price on Procter & Gamble from $164.00 to $180.00 and gave the company an "overweight" rating in a research note on Friday, October 23rd. Barclays raised their target price on Procter & Gamble from $152.00 to $165.00 and gave the stock an "equal weight" rating in a research report on Monday, October 26th. BNP Paribas Exane lifted their price target on shares of Procter & Gamble from $177.00 to $189.00 and gave the stock an "outperform" rating in a research note on Friday, October 23rd. Finally, HSBC lowered shares of Procter & Gamble from a "buy" rating to a "hold" rating and lowered their price target for the company from $182.00 to $149.00 in a report on Thursday, July 30th. Fifteen research analysts have rated the stock with a Buy rating and eleven have given a Hold rating to the stock. Based on data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $170.57.
View Our Latest Analysis on PG
Insider Buying and Selling
In other news, insider Victor Aguilar sold 18,812 shares of the company's stock in a transaction dated Friday, October 30th. The shares were sold at an average price of $164.43, for a total transaction of $3,093,257.16. Following the completion of the transaction, the insider owned 55,243 shares of the company's stock, valued at approximately $9,083,606.49. This represents a 25.40% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Andre Schulten sold 30,677 shares of Procter & Gamble stock in a transaction dated Thursday, November 5th. The stock was sold at an average price of $169.00, for a total value of $5,184,413.00. Following the sale, the chief financial officer directly owned 65,618 shares in the company, valued at approximately $11,089,442. This trade represents a 31.86% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last ninety days, insiders sold 200,006 shares of company stock worth $32,715,058. 0.23% of the stock is currently owned by corporate insiders.
Institutional Investors Weigh In On Procter & Gamble
A number of hedge funds have recently made changes to their positions in PG. Mowery & Schoenfeld Wealth Management LLC acquired a new position in shares of Procter & Gamble in the 2nd quarter worth approximately $26,000. Montgomery Financial Services LLC bought a new stake in Procter & Gamble during the 2nd quarter worth approximately $28,000. Paladin Partners LLC bought a new stake in Procter & Gamble during the 2nd quarter worth approximately $29,000. Toews Corp ADV acquired a new stake in Procter & Gamble during the 2nd quarter valued at $37,000. Finally, Harborfront Financial Group LLC acquired a new stake in Procter & Gamble during the 2nd quarter valued at $38,000. Institutional investors and hedge funds own 65.77% of the company's stock.
Procter & Gamble Company Profile
(
Get Free Report)
The Procter & Gamble Company is a consumer goods company that develops, manufactures and markets products for everyday use. Founded in 1837 by William Procter and James Gamble, the company is headquartered in Cincinnati, Ohio. Its products span beauty, grooming, health care, fabric and home care, and baby, feminine and family care. Well-known brands include Tide, Pampers, Gillette, Pantene, Olay, Oral-B, Crest, Dawn, Charmin and Bounty. Procter & Gamble sells its products in markets around the world through retail stores, e-commerce platforms and other distribution channels.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
A strong long-term portfolio starts with companies that can survive recessions, inflation, changing consumer habits, and shifting market leadership.
This report names seven blue-chip stocks across technology, retail, consumer staples, healthcare, networking, sporting goods, and utilities that offer investors a mix of stability, income, growth, and staying power.
Get This Free Report
Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Like this article? Share it with a colleague.
Link copied to clipboard.